It has not been approved by the Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease
The cells home to the worst areas of cartilage and ligament wear
Documented mechanisms of action Preclinical studies (mostly Russian, to be reproduced in international protocols) report several mechanistic targets: BDNF increase (Brain-Derived Neurotrophic Factor) in the hippocampus and frontal cortex, measured by ELISA and Western blot 24-72 h post-administration Monoaminergic system modulation : cortical dopamine increase, serotonergic modulation Activation of the melanocortin pathway via MC4R receptors (residue shared with ACTH) Anti-oxidant and anti-apoptotic effect in cerebral ischaemia models (MCAO, middle cerebral artery occlusion) Experimental paradigms The most reported rodent models are the Morris water maze (spatial memory), novel object recognition (recognition memory), passive avoidance (aversive learning)
doi: 10.1021/ACSABM.1C00078 106 LiakosI
RHMD - BPC-157 Peptide Therapy Beverly Hills: Discusses BPC-157's therapeutic potential for healing, inflammation, and recovery
How does BPC-157's angiogenesis compare to VEGF